| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TECHBio-Techne Corporation | 10.9B | 69.96 | 152.09 | 5.23% | 6.41% | 3.97% | 2.35% | 0.23 |
| SPRYARS Pharmaceuticals, Inc. | 1.1B | 11.09 | 142.00 | 2970.63% | -56.06% | -54.21% | 1.18% | 0.00 |
| VCYTVeracyte, Inc. | 3.24B | 41.00 | 132.26 | 23.46% | 6.12% | 2.41% | 1.97% | 0.04 |
| CSBRChampions Oncology, Inc. | 99.56M | 7.17 | 21.73 | 13.54% | 4.32% | 59.65% | 7.03% | 1.62 |
| MDXGMiMedx Group, Inc. | 851.59M | 5.75 | 20.54 | 8.52% | 10.38% | 17.09% | 7.58% | 0.13 |
| LTRNLantern Pharma Inc. | 39.26M | 3.51 | -0.00 | -197.36% | 0.01 | |||
| SEERSeer, Inc. | 107.44M | 1.91 | -1.37 | -8.13% | -486.02% | -29.19% | 0.08 | |
| IMDXInsight Molecular Diagnostics Inc. | 189.76M | 6.62 | -1.42 | 25.15% | -13.81% | -14.81% |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 2.13M | 5.63M | 5.63M | 1.31M | 1.22M | 709K | 2.39M |
| Revenue Growth % | - | 1.64% | -0% | -0.77% | -0.06% | -0.42% | 2.37% |
| Cost of Goods Sold | 1.45M | 3.8M | 3.8M | 716K | 725K | 488K | 508K |
| COGS % of Revenue | 0.68% | 0.68% | 0.68% | 0.55% | 0.59% | 0.69% | 0.21% |
| Gross Profit | 680.65K | 1.83M | 1.83M | 590K | 497K | 221K | 1.88M |
| Gross Margin % | 0.32% | 0.32% | 0.32% | 0.45% | 0.41% | 0.31% | 0.79% |
| Gross Profit Growth % | - | 1.68% | -0% | -0.68% | -0.16% | -0.56% | 7.52% |
| Operating Expenses | 7.04M | 5.6M | 5.6M | 18.05M | 18.54M | 21.25M | 18.41M |
| OpEx % of Revenue | 3.3% | 1% | 1% | 13.82% | 15.17% | 29.97% | 7.69% |
| Selling, General & Admin | 3.17M | 2.93M | 2.93M | 10.95M | 9.17M | 12.18M | 10.27M |
| SG&A % of Revenue | 1.48% | 0.52% | 0.52% | 8.39% | 7.5% | 17.18% | 4.29% |
| Research & Development | 3.88M | 2.67M | 2.67M | 7.09M | 9.37M | 9.07M | 8.14M |
| R&D % of Revenue | 1.82% | 0.48% | 0.48% | 5.43% | 7.67% | 12.79% | 3.4% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.36M | -3.78M | -3.78M | -17.46M | -18.04M | -21.03M | -16.52M |
| Operating Margin % | -2.98% | -0.67% | -0.67% | -13.37% | -14.77% | -29.66% | -6.91% |
| Operating Income Growth % | - | 0.41% | 0% | -3.62% | -0.03% | -0.17% | 0.21% |
| EBITDA | -5.61M | -3.01M | -2.99M | -16.54M | -17.15M | -20.08M | -15.56M |
| EBITDA Margin % | -2.63% | -0.53% | -0.53% | -12.67% | -14.03% | -28.33% | -6.51% |
| EBITDA Growth % | - | 0.46% | 0.01% | -4.53% | -0.04% | -0.17% | 0.23% |
| D&A (Non-Cash Add-back) | 745.77K | 768.84K | 785K | 914K | 893K | 946K | 958K |
| EBIT | -6.34M | -3.71M | -3.71M | -17.04M | -18.04M | -21.03M | -16.52M |
| Net Interest Income | 23.82K | 2.77K | -6.4K | -4K | 0 | 0 | 0 |
| Interest Income | 23.82K | 2.94K | 139 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 169 | 6.54K | 4K | 0 | 0 | 0 |
| Other Income/Expense | 23.82K | 57.47K | 57K | 411K | -792K | -384K | 549K |
| Pretax Income | -6.34M | -3.72M | -3.72M | -17.05M | -18.84M | -21.41M | -15.97M |
| Pretax Margin % | -2.97% | -0.66% | -0.66% | -13.05% | -15.41% | -30.2% | -6.68% |
| Income Tax | 23.82K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -6.34M | -3.72M | -3.72M | -17.05M | -18.84M | -21.41M | -15.97M |
| Net Margin % | -2.97% | -0.66% | -0.66% | -13.05% | -15.41% | -30.2% | -6.68% |
| Net Income Growth % | - | 0.41% | -0% | -3.58% | -0.11% | -0.14% | 0.25% |
| Net Income (Continuing) | -6.34M | -3.72M | -3.72M | -17.05M | -18.84M | -21.41M | -15.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.98 | -1.87 | -2.21 | -9.00 | -9.00 | -10.22 | -1.07 |
| EPS Growth % | - | 0.53% | -0.18% | -3.07% | 0% | -0.14% | 0.9% |
| EPS (Basic) | -3.98 | -1.87 | -2.21 | -9.00 | -9.00 | -10.22 | -1.07 |
| Diluted Shares Outstanding | 1.59M | 1.6M | 1.69M | 1.89M | 2.1M | 2.17M | 14.89M |
| Basic Shares Outstanding | 1.59M | 1.6M | 1.69M | 1.89M | 2.1M | 2.17M | 14.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 4.16M | 2.37M | 1.85M | 35.38M | 20.28M | 5.85M | 19.62M |
| Cash & Short-Term Investments | 4.03M | 1.87M | 816K | 35.04M | 19.66M | 5.36M | 19.23M |
| Cash Only | 4.03M | 1.87M | 816K | 25.66M | 10.5M | 4.95M | 19.23M |
| Short-Term Investments | 0 | 0 | 0 | 9.38M | 9.15M | 412K | 0 |
| Accounts Receivable | 0 | 451.46K | 420K | 55K | 218K | 111K | 84K |
| Days Sales Outstanding | - | 29.27 | 27.23 | 15.37 | 65.11 | 57.14 | 12.82 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 561K | 0 | 404K | 376K | 308K |
| Total Non-Current Assets | 6.36M | 8.21M | 7.39M | 7.39M | 7.13M | 6.23M | 5.93M |
| Property, Plant & Equipment | 4.76M | 6.48M | 5.67M | 4.88M | 4.48M | 3.75M | 3.33M |
| Fixed Asset Turnover | 0.45x | 0.87x | 0.99x | 0.27x | 0.27x | 0.19x | 0.72x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.35M | 1.48M | 1.55M | 2.33M | 2.41M | 2.29M | 2.4M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 250.89K | 250.89K | 177K | 177K | 244K | 193K | 202K |
| Total Assets | 10.52M | 10.58M | 9.24M | 42.77M | 27.41M | 12.08M | 25.56M |
| Asset Turnover | 0.20x | 0.53x | 0.61x | 0.03x | 0.04x | 0.06x | 0.09x |
| Asset Growth % | - | 0.01% | -0.13% | 3.63% | -0.36% | -0.56% | 1.12% |
| Total Current Liabilities | 1.86M | 2.49M | 3.83M | 2.71M | 4.87M | 3.89M | 2.58M |
| Accounts Payable | 1.21M | 1.15M | 1.59M | 645K | 1.75M | 638K | 99K |
| Days Payables Outstanding | 302.57 | 110.82 | 152.6 | 328.81 | 881.54 | 477.19 | 71.13 |
| Short-Term Debt | 0 | 0 | 177K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 405K | 541.79K | 10K | 199K | 506K | 506K | 40K |
| Other Current Liabilities | 209.26K | 0 | 0 | 0 | 1.4M | 0 | 0 |
| Current Ratio | 2.24x | 0.95x | 0.48x | 13.06x | 4.17x | 1.50x | 7.60x |
| Quick Ratio | 2.24x | 0.95x | 0.48x | 13.06x | 4.17x | 1.50x | 7.60x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.84M | 3.65M | 3.45M | 2.6M | 2.04M | 1.45M | 1.09M |
| Long-Term Debt | 0 | 0 | 311K | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 3.65M | 3.14M | 2.6M | 2.04M | 1.45M | 824K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.84M | 0 | 0 | 0 | 0 | 0 | 265K |
| Total Liabilities | 3.71M | 6.14M | 7.28M | 5.31M | 6.91M | 5.34M | 3.67M |
| Total Debt | 0 | 4.14M | 4.14M | 3.14M | 2.6M | 2.04M | 1.45M |
| Net Debt | -4.03M | 2.27M | 3.33M | -22.52M | -7.9M | -2.91M | -17.79M |
| Debt / Equity | - | 0.93x | 2.12x | 0.08x | 0.13x | 0.30x | 0.07x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | -22356.67x | -577.59x | -4364.00x | - | - | - |
| Total Equity | 6.81M | 4.45M | 1.96M | 37.45M | 20.5M | 6.74M | 21.89M |
| Equity Growth % | - | -0.35% | -0.56% | 18.14% | -0.45% | -0.67% | 2.25% |
| Book Value per Share | 4.28 | 2.78 | 1.16 | 19.80 | 9.78 | 3.10 | 1.47 |
| Total Shareholders' Equity | 6.81M | 4.45M | 1.96M | 37.45M | 20.5M | 6.74M | 21.89M |
| Common Stock | 7.11M | 0 | 1.96M | 21K | 21K | 2K | 14K |
| Retained Earnings | 0 | 0 | 0 | -43.94M | -62.77M | -84.98M | -109.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.39M | 0 | 0 | 0 | -357K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -5.18M | -2.39M | -2.36M | -9.64M | -13.97M | -19M | -13.87M |
| Operating CF Margin % | -2.43% | -0.42% | -0.42% | -7.38% | -11.43% | -26.8% | -5.8% |
| Operating CF Growth % | - | 0.54% | 0.01% | -3.08% | -0.45% | -0.36% | 0.27% |
| Net Income | -6.34M | -2.96M | -3.72M | -17.05M | -18.84M | -21.41M | -15.97M |
| Depreciation & Amortization | 745.77K | 768.84K | 785.44K | 914K | 893K | 946K | 958K |
| Stock-Based Compensation | 423.87K | 136.85K | 83K | 7.74M | 2.17M | 2.03M | 2.33M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.9M | -120.13K | -167 | -155K | 1.57M | -603K | 60K |
| Working Capital Changes | -11.22K | -216.48K | 488.63K | -1.09M | 238K | 36K | -1.24M |
| Change in Receivables | 24.88K | -451.46K | 30.81K | 366K | -164K | 107K | 27K |
| Change in Inventory | 0 | 0 | -30.81K | -366K | 0 | 0 | 0 |
| Change in Payables | -13.09K | 0 | 130.94K | -945K | 1.11M | 0 | -540K |
| Cash from Investing | -211.68K | -125.05K | -261.5K | -10.7M | -677K | 8.19M | -640K |
| Capital Expenditures | -211.68K | -37.57K | -261.5K | -1.31M | -856K | -301K | -992K |
| CapEx % of Revenue | 0.1% | 0.01% | 0.05% | 1% | 0.7% | 0.42% | 0.41% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -115.72K | -87.47K | 0 | -9.39M | 0 | 8.49M | 0 |
| Cash from Financing | 1.35M | 350K | 1.58M | 45.17M | -509K | 5.26M | 28.79M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | -8.65M |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 1.35M | 350K | -12.67K | -451K | -511K | 5.44M | 24.57M |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -5.39M | -2.43M | -2.63M | -10.95M | -14.82M | -19.3M | -14.86M |
| FCF Margin % | -2.52% | -0.43% | -0.47% | -8.38% | -12.13% | -27.23% | -6.21% |
| FCF Growth % | - | 0.55% | -0.08% | -3.17% | -0.35% | -0.3% | 0.23% |
| FCF per Share | -3.39 | -1.52 | -1.56 | -5.79 | -7.07 | -8.88 | -1.00 |
| FCF Conversion (FCF/Net Income) | 0.82x | 0.64x | 0.64x | 0.57x | 0.74x | 0.89x | 0.87x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -92.99% | -66.09% | -116.24% | -86.5% | -65% | -157.19% | -111.59% |
| Return on Invested Capital (ROIC) | -171.44% | -59.66% | -47.23% | -129.5% | -98.27% | -191.89% | -312.33% |
| Gross Margin | 31.88% | 32.44% | 32.44% | 45.18% | 40.67% | 31.17% | 78.76% |
| Net Margin | -296.84% | -66.09% | -66.1% | -1305.13% | -1541.33% | -3020.17% | -667.77% |
| Debt / Equity | - | 0.93x | 2.12x | 0.08x | 0.13x | 0.30x | 0.07x |
| Interest Coverage | - | -22356.67x | -577.59x | -4364.00x | - | - | - |
| FCF Conversion | 0.82x | 0.64x | 0.64x | 0.57x | 0.74x | 0.89x | 0.87x |
| Revenue Growth | - | 163.71% | -0.01% | -76.8% | -6.43% | -41.98% | 237.38% |
Longeveron Inc. (LGVN) reported $1.4M in revenue for fiscal year 2024. This represents a 33% decrease from $2.1M in 2018.
Longeveron Inc. (LGVN) grew revenue by 237.4% over the past year. This is strong growth.
Longeveron Inc. (LGVN) reported a net loss of $21.3M for fiscal year 2024.
Yes, Longeveron Inc. (LGVN) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.
Longeveron Inc. (LGVN) has a return on equity (ROE) of -111.6%. Negative ROE indicates the company is unprofitable.
Longeveron Inc. (LGVN) had negative free cash flow of $17.0M in fiscal year 2024, likely due to heavy capital investments.